Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,108.40
(
-0.41%
)
US TECH 100
26,203.20
(
0.00%
)
Dow Jones
49,310.32
(
-0.36%
)
Brent Oil
101.10
(
-0.10%
)
Bitcoin
78,441.50
(
0.21%
)
News Focus
News Focus
Post# of 257441
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 54
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: DewDiligence post# 35277

Wednesday, 10/11/2006 10:56:46 AM

Wednesday, October 11, 2006 10:56:46 AM

Post# of 257441
Re: NFLD Fast Track (maybe)

If the data are beyond any hint of rapproach, they'll get Fast Track. If not, they'll get full review. I think it has next to nothing to do with superiority/non-inferiority. Given the political heat about this drug and trial, deserved or undeserved it does not matter, I would be very surprised to see a 6-month review.

Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today